Evidence map›Paper›PMID 42411734›Full record

ArticleRevista de neurologia2026

Jiangtao Liang, Feng Li, Zhongxiang Ding, Bing Yan, Yanfang Zhu, Fangxiao Wang, Weiling Xuan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Revista de neurologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiangtao LiangHangzhou Universal Medical Imaging Diagnostic Center, 310009 Hangzhou, Zhejiang, China.
Feng LiHangzhou Universal Medical Imaging Diagnostic Center, 310009 Hangzhou, Zhejiang, China.
Zhongxiang DingDepartment of Radiology, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, 310006 Hangzhou, Zhejiang, China.
Bing YanDepartment of Radiology, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, 310006 Hangzhou, Zhejiang, China.
Yanfang ZhuHangzhou Universal Medical Imaging Diagnostic Center, 310009 Hangzhou, Zhejiang, China.
Fangxiao WangHangzhou Universal Medical Imaging Diagnostic Center, 310009 Hangzhou, Zhejiang, China.
Weiling XuanHangzhou Xixi Hospital Affiliated to Zhejiang Chinese Medical University, 310023 Hangzhou, Zhejiang, China.

Funding

Medical Science and Technology Project of Zhejiang Province 2022KY1047Medical Science and Technology Project of Zhejiang Province 2024KY1428
6 · The paper itself

Abstract

backgroundThis study aimed to explore the value of multiparameter imaging features of

methodsA retrospective analysis of the clinical and PET/MRI imaging data of 121 children with HR-NB who were examined at our center between December 2018 and December 2025. According to the tumor

resultsThe imaging-defined risk factor (IDRF) positivity rate, proportion of stage M cases, and detection rates of tumor necrosis and hemorrhage were significantly higher in the MNA group than in the MYCN-NA group (all

conclusionThe predictive model constructed by combining SUV

Indexed as

Fluorodeoxyglucose F18Gene AmplificationMagnetic Resonance ImagingMultiparametric Magnetic Resonance ImagingNeuroblastomaN-Myc Proto-Oncogene ProteinPositron-Emission TomographyChildChild, PreschoolFemaleHumansInfantMalePredictive Value of TestsRadiopharmaceuticalsRetrospective StudiesFluorodeoxyglucose F18MYCN protein, humanN-Myc Proto-Oncogene ProteinRadiopharmaceuticalsmagnetic resonance imagingneuroblastomapositron emission tomography

Identifiers

PMID42411734
PMCPMC13339796

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.